BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14696098)

  • 1. Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.
    Ito K; Fujita T; Akada M; Kiniwa Y; Tsukamoto M; Yamamoto A; Matsuzaki Y; Matsushita M; Asano T; Nakashima J; Tachibana M; Hayakawa M; Ikeda H; Murai M; Kawakami Y
    Int J Cancer; 2004 Feb; 108(5):712-24. PubMed ID: 14696098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lung.
    Sugaya M; Takenoyama M; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
    Int J Cancer; 2007 Mar; 120(5):1055-62. PubMed ID: 17131342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses.
    Monji M; Nakatsura T; Senju S; Yoshitake Y; Sawatsubashi M; Shinohara M; Kageshita T; Ono T; Inokuchi A; Nishimura Y
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6047-57. PubMed ID: 15447989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24+ cancer patients.
    Homma S; Harada M; Yano H; Ogasawara S; Shichijo S; Matsueda S; Komatsu N; Shomura H; Maeda Y; Sato Y; Todo S; Itoh K
    Int J Oncol; 2006 Sep; 29(3):577-87. PubMed ID: 16865273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.
    Yang D; Nakao M; Shichijo S; Sasatomi T; Takasu H; Matsumoto H; Mori K; Hayashi A; Yamana H; Shirouzu K; Itoh K
    Cancer Res; 1999 Aug; 59(16):4056-63. PubMed ID: 10463607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
    Hayashi E; Matsuzaki Y; Hasegawa G; Yaguchi T; Kurihara S; Fujita T; Kageshita T; Sano M; Kawakami Y
    Clin Cancer Res; 2007 Nov; 13(21):6267-74. PubMed ID: 17975137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.
    Kawano K; Gomi S; Tanaka K; Tsuda N; Kamura T; Itoh K; Yamada A
    Cancer Res; 2000 Jul; 60(13):3550-8. PubMed ID: 10910068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
    Ishikawa T; Fujita T; Suzuki Y; Okabe S; Yuasa Y; Iwai T; Kawakami Y
    Cancer Res; 2003 Sep; 63(17):5564-72. PubMed ID: 14500396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antigen recognized by autologous CTLs on a human bladder carcinoma.
    Guéguen M; Patard JJ; Gaugler B; Brasseur F; Renauld JC; Van Cangh PJ; Boon T; Van den Eynde BJ
    J Immunol; 1998 Jun; 160(12):6188-94. PubMed ID: 9637538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
    Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
    Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.
    Güre AO; Altorki NK; Stockert E; Scanlan MJ; Old LJ; Chen YT
    Cancer Res; 1998 Mar; 58(5):1034-41. PubMed ID: 9500467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
    Okada T; Akada M; Fujita T; Iwata T; Goto Y; Kido K; Okada T; Matsuzaki Y; Kobayashi K; Matsuno S; Sunamura M; Kawakami Y
    Clin Cancer Res; 2006 Jan; 12(1):191-7. PubMed ID: 16397042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
    Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N
    Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, isolation and characterization of human tumor in situ monoclonal antibodies.
    Wu H; Pancook JD; Beuerlein G; Chilton T; Pecht G; Huse WD; Watkins JD
    Cancer Immunol Immunother; 2002 Apr; 51(2):79-90. PubMed ID: 11904732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T; Yagita H; Hashimoto Y
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological identification of immunogenic antigens in acute monocytic leukemia.
    Chen G; Zhang W; Cao X; Li F; Liu X; Yao L
    Leuk Res; 2005 May; 29(5):503-9. PubMed ID: 15755502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.
    Otani S; Sakurai T; Yamamoto K; Fujita T; Matsuzaki Y; Goto Y; Ando Y; Suzuki S; Usui M; Takeuchi M; Kawakami Y
    Br J Ophthalmol; 2006 Jun; 90(6):773-7. PubMed ID: 16481377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and peptide analyses of newly defined lung cancer antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.
    Yamada A; Kawano K; Koga M; Takamori S; Nakagawa M; Itoh K
    Cancer Res; 2003 Jun; 63(11):2829-35. PubMed ID: 12782588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.